Cantor Fitzgerald Reiterates Overweight on Teradyne, Maintains $550 Price Target

Benzinga · 2d ago
Cantor Fitzgerald analyst C.J. Muse reiterates Teradyne (NASDAQ:TER) with a Overweight and maintains $550 price target.